Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers from Department of Experimental Psychology have found that, during lockdown, teenagers mental health is struggling compared to their parents.

School bag and equipment next to a face mask

The Oxford ARC study, launched in May, has found that teenagers consistently report higher levels of anxiety and depression than parents. Around 35% of teenagers are saying they feel lonely often or most of the time, compared to 17% of parents. At the same time, about 40% of parents say they never feel lonely, compared to only 20% of teenagers. Since May, teenagers consistently reported that they felt unable to control the important things in life, with rates as high as 60% last month.

Now, millions of teenagers are returning to school. Far from being a typical return to school after summer break, this year’s students will bring with them unique experiences, worries, and traumas from lockdown during this global pandemic lockdown.

The Oxford ARC study, is launching a new phase of research in order to understand how certain aspects of the school experience are helping or harming young people’s mental health during the transition back to school and into the ‘new normal’. Teenagers interested in taking part can go to the Oxford ARC website to find out more.

The full story is available on the University of Oxford website

This story is also discussed in a Department of Experimental Psychology blog

Similar stories

Oxford-led team given £6.6m to map uncharted networks in the progression of Parkinson’s

A major new $9 million (£6.6 million) project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. It is the only UK-led ASAP project this year, and the first ever to be led by Oxford.

Tamoxifen repurposing study shows no benefit in treating deadly fungal meningitis

Hopes that tamoxifen could improve survival for a deadly form of fungal meningitis have been dashed by the results of a clinical trial conducted by University of Oxford researchers and published today in eLife.

Oxford researchers awarded funding to complete community COVID-19 antiviral trial

Researchers from the Nuffield Department of Primary Care Health Sciences, University of Oxford, have today announced that they have been awarded funding through the National Institute for Health Research (NIHR) to work with several UK universities and carry out a first-of-its-kind clinical trial, testing novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 who are at higher risk of complications.

New therapeutic targets identified to treat inflammatory bowel disease

Millions of patients with ulcerative colitis or Crohn’s disease, collectively known as inflammatory bowel disease (IBD), are given fresh hope as a new study shows why some of them do not respond to current treatments.

Oxford researchers call for an urgent re-evaluation of “weak” opioid safety profile

A new study associates dispensation doses of tramadol with increased risk of mortality, cardiovascular events, and fractures compared to the use of codeine to treat pain.

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.